The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The losartan potassium active pharmaceutical ingredient (api) market size has demonstrated significant expansion in recent years. It is anticipated to increase from $1.85 billion in 2025 to $1.97 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.5%. The historical growth of this market stemmed from factors including the rising occurrence of hypertension, the expiration of branded drug patents, the proliferation of generic pharmaceutical manufacturing, an increased need for cardiovascular drugs, and the expansion of global pharmaceutical supply chains.
The losartan potassium active pharmaceutical ingredient (API) market is projected to experience substantial expansion in the coming years. This market is set to reach $2.54 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this anticipated growth include a rising prevalence of cardiovascular diseases, heightened demand from developing economies, innovations in API manufacturing processes, a greater emphasis on environmentally sound pharmaceutical production, and broader applications in chronic kidney disease treatment. Key developments expected during this forecast period encompass a surge in demand for generic losartan formulations, wider implementation of continuous flow API manufacturing, a growing pursuit of economical antihypertensive APIs, an increase in losartan API integration into combination therapies, and a heightened commitment to API production that adheres to regulatory standards.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
What Drivers Are Influencing The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The expanding occurrence of hypertension is anticipated to fuel the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. Hypertension, characterized by continuously elevated blood pressure, increases the risk of heart ailments, strokes, and other serious medical issues. The rising frequency of hypertension is associated with diets high in sodium and processed items, contributing to fluid buildup and greater stress on the heart. Losartan potassium aids in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action allows vessels to relax and expand, thereby reducing blood pressure and alleviating the heart’s effort. As an illustration, in September 2025, the World Health Organization (WHO), a global health authority situated in Geneva, Switzerland, reported that approximately 1.4 billion adults aged 30–79 years experienced hypertension in 2024, a notable increase from the roughly 1.3 billion adults affected in 2022. Consequently, the increasing occurrence of hypertension is propelling the expansion of the losartan potassium active pharmaceutical ingredient (API) market.
What Major Segment Divisions Exist Within The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
How Are Trends Shaping The Direction Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Major companies operating within the losartan potassium active pharmaceutical ingredient (API) market are prioritizing the creation of innovative products and obtaining regulatory clearances, such as for losartan potassium oral suspension, to improve patient adherence and expand its therapeutic uses. Losartan potassium oral suspension represents a liquid form of the losartan potassium medication, designed for individuals who have trouble swallowing tablets. As an illustration, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical firm, secured Food and Drug Administration (FDA) approval for Arbli. Arbli is a ready-to-use liquid formulation indicated for hypertension, reducing the risk of stroke in hypertensive patients with left ventricular hypertrophy, and treating diabetic nephropathy in type 2 diabetes patients. It facilitates accurate dosing without requiring compounding and is offered as a 165 mL peppermint-flavored suspension (10 mg/mL), boasting an 18-month shelf life at room temperature.
Which Companies Are Leading Innovation In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Major companies operating in the losartan potassium active pharmaceutical ingredient (api) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
Read the full losartan potassium active pharmaceutical ingredient (api) market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
North America was the largest region in the losartan potassium API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (api) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Losartan Potassium Active Pharmaceutical Ingredient (API) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp
Browse Through More Reports Similar to the Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market 2026, By The Business Research Company
Active Pharmaceutical Ingredients Market Report 2026
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model